Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The prevalence of TTR cardiac amyloidosis among patients undergoing bone scintigraphy.

Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology - 1 Jun 2021

Bianco Matteo, Parente A, Biolè C, Righetti C, Spirito A, Luciano A, Destefanis P, Nangeroni G, Angusti T, Anselmino M, Montagna L

Abstract excerpt

BACKGROUND: Radiolabeled bisphosphonates bone scintigraphy is highly sensitive in detecting transthyretin (TTR) cardiac amyloidosis; data on the true prevalence of cardiac involvement in TTR amyloidosis are lacking. METHODS AND RESULTS: This retrospective observational, monocentric study aims to estimate the prevalence of positive bone scan suspect for TTR cardiac amyloidosis among an all-comers population who...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amyloidosis
Share to Bone and Bones

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Echocardiography

Share to Electrocardiography

Share to Prealbumin

Share to Prevalence

Share to Radionuclide Imaging

Source

Identifiers

PMID: 33728572
DOI: 10.1007/s12350-021-02575-0

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The prevalence of TTR cardiac amyloidosis among patients undergoing bone scintigraphy.PMID 33728572Read ↗

Low Sensitivity of Bone Scintigraphy in Detecting Phe64Leu Mutation-Related Transthyretin Cardiac Amyloidosis.Semantic proximity Read ↗

Redefining the epidemiology of cardiac amyloidosis. A systematic review and meta-analysis of screening studies.Semantic proximity Read ↗

Cardiac amyloidosis: when to suspect and how to confirm.Semantic proximity Read ↗

Detecting early cardiomyopathy in transthyretin variant carriers: reappraising the diagnostic value of Perugini Grade 1 radiotracer uptake on bone scintigraphySemantic proximity Read ↗

ATTR Epidemiology, Genetics, and Prognostic FactorsSemantic proximity Read ↗

Transthyretin amyloidosis cardiomyopathy in Greece: Clinical insights from the National Referral Center.Semantic proximity Read ↗

Cardiac amyloidosis: the great pretender.Semantic proximity Read ↗

Not So Rare After All: Rethinking Hereditary Transthyretin AmyloidosisSemantic proximity Read ↗

Transthyretin cardiac amyloid: Broad heart failure phenotypic spectrum and implications for diagnosis.Semantic proximity Read ↗

Changes in amyloidosis phenotype over 11 years in a cardiac amyloidosis referral centre cohort in France.Semantic proximity Read ↗

Soft Tissue-to-Bone Ratio on Routine Bone Scintigraphy as an Opportunistic Imaging Biomarker of Cardiovascular-Kidney-Metabolic BurdenSemantic proximity Read ↗

Multi-Imaging Characterization of Cardiac Phenotype in Different Types of Amyloidosis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.